Vakrangee share news, announcements and annual reports
NSE: VAKRANGEEBSE: 511431IT - ServicesSmall Cap
Vakrangee Limited · Formerly Vakrangee Softwares · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1994 on BSE, Apr 2006 on NSE
Last close ₹5.56₹0.00 (0.00%)BSE ₹5.57
Share price at the NSE close on 2 Nov 2026. Previous close ₹5.56.
2 Nov: open ₹5.66, high ₹5.80, low ₹5.45
52-week range of traded prices to 2 Nov 2026
₹4.61Low, 30 Mar 2026₹8.85High, 13 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹602 Cr1,674th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 55.46
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.76
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 13,65,57347.8% delivered
Vakrangee share news and announcements
997 announcements, routine notices left out, newest first. Page 15 of 20.
Mar 2015
Feb 2015
14 Feb · Updates
6 Feb · Board meeting
Inter-alia, to consider and approve Un-audited Financial Result of the Company for the quarter ended December 31, 2014.
Dec 2014
22 Dec · Meeting Updates
4 Dec · Board meeting
1 Dec · Board meeting
To inter alia transact the following business: (1) To discuss on the Payments Banks Guidelines issued by the Reserve Bank of India and applying for the license for the Payments Bank in the capacity of Corporate Business Correspondent. (2) To consider and appoint Mr. T. Sitharthan as Nominee director, representing the Life Insurance Corporation of India on the board of the company. (3) To discuss and consider change in logo and tag lines of the company and the projects undertaken /to be undertaken by the Company.
Nov 2014
14 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 14, 2014, inter-alia has transacted the following businesses: 1. Appointed Mr. Avinash Vyas as an Additional Director (Independent) on the board of the Company. 2. However Agenda No. 5 of the Notice of Board Meeting dated November 05, 2014 for appointment of Mr. T. Sitharthan as a Nominee Director, could not be taken up in this Board meeting and hence may be considered in the forthcoming Board Meeting.14 Nov · Updates
5 Nov · Board meeting
To inter-alia transact the following business: 1. To consider and approve Un-audited Financial Results of the Company for the quarter ended September 30, 2014. 2. To consider and approve appointment of Mr. T. Sitharthan as a Nominee director, representing the Life Insurance Corporation of India on the board of the company. 3. To consider and approve appointment of Mr. Avinash Vyas as an additional director (Independent Director), on the board of the company.
Oct 2014
8 Oct · Disclosure of Voting Pattern - Clause 35A
Sep 2014
1 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2014 to September 30, 2014 (both days inclusive) for the purpose of Dividend and Annual General Meeting of the Company to be held on September 30, 2014.1 Sep · Board meeting
Aug 2014
25 Aug · Board meeting
To inter-alia transact the following business: (1) To consider and approve draft Directors' Report, Management Discussion and Analysis and Corporate Governance Report for the year ended March 31, 2014. (2)To consider and approve Audited Financial Results of the Company for the year ended March 31, 2014. (3)To finalize the dates of Closure of Register of Members and Share Transfer Books (Book Closure Dates) of the Company for the purpose of ensuing Annual General Meeting. (4)To fix the day, date, time and venue for the Annual General meeting of the company. (5) To consider and approve the draft notice for the Annual General Meeting of the Company. (6)To consider and approve Corporate Social Responsibility (CSR) policy proposed by the CSR Committee of the Board of Directors of the company (7)To consider and decide on Appointment of Scrutinizer for conducting E-Voting and voting through Poll at Annual General Meeting4 Aug · Meeting
Jul 2014
9 Jul · Board meeting
To inter-alia, consider & approve un-audited Financial Results of the Company for the quarter ended June 30, 2014.
Jun 2014
30 Jun · Board meeting
Inter alia, to transact the following business: 1. To consider and approve fund raising by way of Qualified Institutional Placement (QIP) by way of issuance of eligible securities to the Qualified Institutional Buyers (QIBs) upto Rs. 1000 Crore (Rupees One Thousand Crore) at such rate as may be decided by the board/ committee as per the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2009, subject to members' approval. 2. To constitute a committee to be called as "QIP Committee" authorized to do all such acts, deeds and things with respect to the aforesaid Qualified Institutional Placement. 3. To consider and approve passing of the Members' resolution for the aforesaid QIP through postal ballot.
May 2014
26 May · Meeting
14 May · Board meeting
Inter alia, to transact the following business: (1) To consider & approve Audited Financial Results of the Company for the year ended March 31, 2014.(2). To recommend final Dividend for the FY 2013-14, if any. (3). To consider and approve appointment of Mr. T Sitharthan as the Nominee Director on the board of the company as proposed by the Life Corporation of India.
Apr 2014
23 Apr · Board meeting
Mar 2014
Feb 2014
25 Feb · Business
Pursuant to Members' resolution passed on February 19, 2014 and In-principal approval received from the concerned Stock Exchanges for the preferential allotment, the Preferential Allotment Committee of the Board of Directors of the Company upon receipt of due consideration amount has, on February 25, 2014 allotted 2,50,00,000 Fully Convertible Warrants to M/s. Vakrangee Capital Private Limited, a Promoter Group Company.20 Feb · Meeting
Jan 2014
20 Jan · Results
10 Jan · Board meeting
Inter alia, to transact the following businesses: 1. To consider & approve Un-audited Financial Results of the Company for the quarter ended December 31, 2013. 2. To consider and approve allotment of such numbers of Fully convertible Warrants, each convertible into equivalent number of Equity Shares having Face Value of Re. 1/- each at such rate as may be decided by the Preferential Allotment Committee on preferential basis to one of the Promoter companies, M/s. Vakrangee Capital Private Limited, as recommended by the said Committee, subject to members approval.
Dec 2013
13 Dec · Business
Remuneration and Compensation Committee of the Board of Directors of the Company at its meeting held on December 13, 2013 has allotted 516920 numbers of Equity Shares having Face Value of Re. 1/- each to the employees of the Company (the Allottees) as per "Vakrangee Limited ESOP Scheme 2008". Post allotment of 516920 shares of face value of Re. 1/- each, the Company's issued and paid-up share capital is at 503482240 Equity Shares of face value of Re. 1/- each amounting to Rs. 50,34,82,240/-.
Nov 2013
21 Nov · Name and Symbol Change
Members of the Exchange are hereby informed that the name of Vakrangee Softwares Limited shall be changed to Vakrangee Limited and the trading symbol of the Company be changed from VAKRANSOFT to VAKRANGEE w.e.f. November 27, 2013.11 Nov · Results
Oct 2013
31 Oct · Board meeting
Inter-alia to consider & approve Un-audited Financial Results of the company for the Quarter ended September 30, 2013.17 Oct · Updates
Preferential Allotment Committee of the Board of Directors of the Company constituted with an objective for the retirement of the debt of the company and for meeting the capital requirement for the asset creation for new projects, at its meeting held on October 16, 2013 considered and approved, subject to members approval, and other regulatory approvals if any, issuance and allotment of the following on preferential basis: (1) Upto 5% Fully Convertible Warrants, each convertible into equivalent number of equity shares to the Promoters of the company, convertible at the sole option of the allottee in one or more tranches at any time after the date of allotment but before expiry of 18 months from the date of allotment, and (2) Upto 15% of equity shares of the company to other strategic investors as may be determined by the committee; All the other information in relation to the above mentioned preferential allotment including but not limited to the object of the said preferential allotment and exercise price determined as per the prescribed pricing norms under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2009 and any amendments made thereto from time to time, for preferential allotment shall be disclosed by the company when decided.